DUSA PHARMACEUTICALS INC (DUSA) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 329 transactions totaling $9.7M, demonstrating a bearish sentiment with -$7.9M in net insider flow. The most recent transaction on Dec 20, 2012 involved a transaction of 10,000 shares valued at $80.0K.
No significant insider buying has been recorded for DUSA in the recent period.
No significant insider selling has been recorded for DUSA in the recent period.
Based on recent SEC filings, insider sentiment for DUSA is bearish with an Insider Alignment Score of 9/100 and a net flow of -$7.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at DUSA PHARMACEUTICALS INC (DUSA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading DUSA stock, having executed 329 transactions in the past 90 days. The most active insider is Hill Partners Llc Cooper (Executive), who has made 3 transactions totaling $10.9M.
Get notified when executives and directors at DUSA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 20, 2012 | Altomari Alfred | Executive | Tender | 10,000 | $8.00 | $80.0K | |
| Dec 20, 2012 | Altomari Alfred | Executive | Tender | 10,000 | $8.00 | $80.0K | |
| Dec 20, 2012 | M. Bartash David | Executive | Tender | 52,125 | $8.00 | $417.0K | |
| Dec 20, 2012 | M. Bartash David | Executive | Tender | 11,875 | $8.00 | $95.0K | |
| Dec 20, 2012 | Carota Mark | Executive | Tender | 39,085 | $8.00 | $312.7K | |
| Dec 20, 2012 | Carota Mark | Executive | Tender | 149,200 | $8.00 | $1.2M | Large |
| Dec 20, 2012 | W. Casdin Alexander | Executive | Tender | 206,000 | $8.00 | $1.6M | Large |
| Dec 20, 2012 | W. Casdin Alexander | Executive | Tender | 10,000 | $8.00 | $80.0K | |
| Dec 20, 2012 | Christopher Richard | Executive | Tender | 209,150 | $8.00 | $1.7M | Large |
| Dec 20, 2012 | Christopher Richard | Executive | Tender | 66,862 | $8.00 | $534.9K | Large |
| Dec 20, 2012 | F. Doman Robert | Executive | Tender | 19,750 | $8.00 | $158.0K | |
| Dec 20, 2012 | F. Doman Robert | Executive | Tender | 138,286 | $8.00 | $1.1M | Large |
| Dec 20, 2012 | F. Doman Robert | Executive | Tender | 528,400 | $8.00 | $4.2M | Large |
| Dec 20, 2012 | M. Haft Jay | Executive | Tender | 13,750 | $8.00 | $110.0K | |
| Dec 20, 2012 | M. Haft Jay | Executive | Tender | 34,500 | $8.00 | $276.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 30 | $19.3M | 48.6% |
Other(J) | 2 | $8.9M | 22.5% |
Sale(S) | 121 | $8.8M | 22.1% |
Purchase(P) | 23 | $901.8K | 2.3% |
Payment(F) | 65 | $797.7K | 2.0% |
Exercise(M) | 19 | $541.2K | 1.4% |
Award(A) | 63 | $449.1K | 1.1% |
Gift(G) | 6 | $0 | 0.0% |
Insider selling pressure at DUSA PHARMACEUTICALS INC has increased, with 25 insiders executing 329 transactions across all time. Total sales of $8.8M significantly outpace purchases of $901.8K, resulting in a net outflow of $7.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.